1. Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. Issue 5 (12th February 2022) Authors: Allsup, David John; Craig, Zoe; Cairns, David; Howard, Dena; Hockaday, Anna; Bloor, Adrian; Soe, Zarni; Pepper, Christopher; Gattei, Valter; Zucchetto, Antonella; Robbe, Pauline; Clifford, Ruth; Schuh, Anna; Munir, Talha; Rawstron, Andrew; Hillmen, Peter Journal: American journal of hematology Issue: Volume 97:Issue 5(2022) Page Start: E168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy. Issue 28 (1st October 2022) Authors: Craig, Zoe; Swain, Jayne; Sharma, Rohini; Faluyi, Olusola Olusesan; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nicholas Simon; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sharmila, Sothi; Anthoney, Alan; Patel, Alkesh; Lamarca, Angela; Hubner, Richard A; ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). Issue 2 (5th February 2020) Authors: Craig, Zoe; Swain, Jayne; Batman, Emma; Wadsley, Jonathan; Reed, Nicholas; Faluyi, Olusola; Cave, Judith; Sharma, Rohini; Chau, Ian; Wall, Lucy; Lamarca, Angela; Hubner, R; Mansoor, Wasat; Sarker, Debashis; Meyer, Tim; Cairns, David A; Howard, Helen; Valle, Juan W; McNamara, Mairéad G Journal: BMJ open Issue: Volume 10:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma. (10th June 2020) Authors: Bygrave, Ceri; Pawlyn, Charlotte; Davies, Faith; Craig, Zoe; Cairns, David; Hockaday, Anna; Jenner, Matthew; Cook, Gordon; Drayson, Mark; Owen, Roger; Gregory, Walter; Morgan, Gareth; Jackson, Graham; Kaiser, Martin Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials. (15th February 2023) Authors: Platt, James R.; Williams, Christopher J. M.; Craig, Zoe; Cairns, David A.; Glasbey, James C.; Morton, Dion; Seligmann, Jenny Journal: Colorectal disease Issue: Volume 25:Number 3(2023) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗